Implanet S.A. (ALIMP.PA) Stock
Implanet S.A., together with its associated companies, is dedicated to the research, development, manufacturing, and commercialization of spinal and orthopedic medical implants. The firm's product portfolio addresses both spinal and knee needs.
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
Peer Comparison
About Implanet S.A.
Implanet S.A., together with its associated companies, is dedicated to the research, development, manufacturing, and commercialization of spinal and orthopedic medical implants. The firm's product portfolio addresses both spinal and knee needs. Its spinal offerings encompass various posterior fixation systems, including the Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Jazz Frame, and ISS-Jazz Screw lines. Furthermore, Implanet S.A. provides knee prostheses, which are marketed under the Madison brand. The company has a significant strategic alliance with Shanghai Sanyou Medical Co, Ltd. Established in 2006, Implanet S.A. operates from its headquarters in Martillac, France.
Implanet S.A. is led by CEO Ludovic Lastennet, employs 46 people, headquartered in Martillac, FR, publicly traded since 2013.
over the past 52 weeks the stock has ranged between $0.15 and $0.45, and currently trades 60.0% below its 52-week high.
Official website: www.implanet.com